← Back to screener

CME GROUP INC. CME

Rank #309 · Nasdaq · $20.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
69.2
P/E
9.6
P/B
0.76
ROE
8.0%
Op. Margin
61.6%
Debt Ratio
419%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★★
Excellent

P/E 9.6x, P/B 0.76x. Ranks in the top 9% of the universe.

Profitability ★★★★☆
Good

ROE 8.0%. Ranks in the top 27% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 419%. Ranks in the top 77% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★☆☆
Good

Revenue growth of 11.1% year over year. Ranks in the top 32% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$2.6B$1.6B$0.8B$18.7B60.880
2012$3.0B$1.8B$1.0B$21.6B61.089
2013$3.3B$2.0B$1.8B$21.4B61.681
2014$2.9B$1.7B$0.9B$21.2B58.1157
2015$2.9B$1.6B$1.0B$20.9B55.8245
2016$3.1B$1.8B$1.1B$20.6B56.8228
2017$3.3B$2.0B$1.5B$20.9B59.8234
2018$3.6B$2.2B$1.5B$20.6B61.2260
2019$3.6B$2.3B$4.1B$20.3B63.4253
2020$4.3B$2.6B$2.0B$26.1B60.5188
2021$4.9B$2.6B$2.1B$26.3B53.2374
2022$4.9B$2.6B$2.1B$27.4B54.0618
2023$4.7B$2.6B$2.6B$26.9B56.4548
2024$5.0B$3.0B$3.2B$26.7B60.1385
2025$5.6B$3.4B$2.1B$26.5B61.6419

← See the full screener